Search

everythinglearnresearchcommunity

for

Search:↓

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Cord blood platelet-rich plasma may safely improve vulvar lichen sclerosus symptoms.

Cupric chloride treatment corrected abnormal Purkinje cell development in brindled mice.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Photobiomodulation therapy is beneficial in plastic surgery and dermatology.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

scMC effectively separates biological signals from technical noise in single-cell genomics data.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

PCOS may start with high insulin levels, and certain biomarkers can help understand its causes, especially in teens.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

High doses of TCB cause severe health issues in marmoset monkeys.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

High 1-hour plasma glucose in PCOS increases risks of metabolic issues and gestational diabetes.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

PBX1 helps reduce aging and cell death in hair follicle stem cells by decreasing DNA damage, not by improving DNA repair.

A new genetic mutation causing Xeroderma Pigmentosum was found in an 8-year-old girl, affecting her DNA repair.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Most women with polycystic ovary syndrome were first diagnosed by their family doctor, who may need to record symptoms better and rely less on ultrasounds.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.